Search Within

Anita Mamtani

Formats
  1. Journal Article (30)
  2. Meeting Abstract (22)
  3. Editorial (6)
  4. Miscellaneous (5)
  5. Review (3)
  6. Book Section (1)
Groups
  1. Surgery (67)
  2. Epidemiology and Biostatistics (34)
  3. Principal Biostatisticians (25)
  4. Survivorship Research (21)
  5. Graduate Medical Education (12)
  6. Josie Robertson Surgery Center (12)

More Groups

People
  1. Monica Morrow (60)
  2. Andrea Barrio (37)
  3. Srinivasa Sevilimedu Veeravalli (25)
  4. Mary Gemignani (16)
  5. Michelle Stempel (15)
  6. Kimberly Van Zee (11)

More People

Years
  1. 2025 (3)
  2. 2024 (2)
  3. 2023 (8)
  4. 2022 (10)
  5. 2021 (10)
  6. 2020 (8)

More Years

Publications
  1. Annals of Surgical Oncology (49)
  2. Breast Cancer Research and Treatment (3)
  3. Cancer (2)
  4. Cancer Research (2)
  5. International Journal of Radiation Oncology, Biology, Physics (2)
  6. Annals of Surgery (1)

More Publications

Publishers
  1. Springer (54)
  2. Elsevier Inc. (3)
  3. American Association for Cancer Research (2)
  4. Wiley Blackwell (2)
  5. American Medical Association (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (67)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research group
    Review

    Corso, G.; Shen, S.; Criscitiello, C.; Mukhtar, R.; Gamble, L.; Rocco, E. G.; Pesapane, F.; Nicosia, L.; Jhaveri, K.; Salimbeni, B. T.; more...
    Cancer Treatment Reviews (2025)

    Fulltext@MSK | Save
  • Omission of routine frozen section for clinically node-negative patients undergoing upfront mastectomy avoids unnecessary axillary treatment
    Journal Article

    Sargent, R. E.; Barrio, A. V.; Sevilimedu, S. V.; Khan, A. J.; Morrow, M.; Mamtani, A.
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • Updates in surgical management of the axilla
    Review

    Mamtani, A.; Barrio, A. V.
    Oncology (Norwalk) (2025)

    Fulltext@MSK | Save
  • Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers
    Journal Article

    Myers, S. P.; Sevilimedu, V.; Barrio, A. V.; Tadros, A. B.; Mamtani, A.; Robson, M. E.; Morrow, M.; Lee, M. K.
    npj Breast Cancer (2024)

    Fulltext@MSK | Save
  • Omission of routine frozen section among clinically node-negative patients having upfront mastectomy avoids unnecessary axillary treatment
    Meeting Abstract

    Sargent, R.; Sevilimedu, V.; Barrio, A. V.; Morrow, M.; Mamtani, A.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Mutational status is associated with a higher rate of pathologic complete response after neoadjuvant chemotherapy in hormone receptor-positive breast cancer
    Journal Article

    Myers, S. P.; Sevilimedu, V.; Barrio, A. V.; Tadros, A. B.; Mamtani, A.; Robson, M. E.; Morrow, M.; Lee, M. K.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Mutational status is associated with higher rate of pathologic complete response after neoadjuvant chemotherapy in hormone receptor-positive breast cancer
    Miscellaneous

    Myers, S. P.; Sevilimedu, V.; Barrio, A. V.; Tadros, A. B.; Mamtani, A.; Robson, M. E.; Morrow, M.; Lee, M. K.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • BRCA mutational status is associated with higher rate of pathologic complete response in hormone receptor-positive breast cancer
    Meeting Abstract

    Myers, S. P.; Walsh, E. M.; Sevilimedu, V.; Barrio, A. V.; Tadros, A. B.; Mamtani, A.; Robson, M. E.; Morrow, M.; Lee, M. K.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Axillary dissection is avoidable in the majority of cT1N0 triple negative and HER2+ breast cancers having upfront surgery with adjuvant radiation
    Meeting Abstract

    Mamtani, A.; Sevilimedu, V.; Barrio, A. V.; Morrow, M.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers
    Meeting Abstract

    Myers, S. P.; Sevilimedu, V.; Barrio, A. V.; Tadros, A.; Mamtani, A.; Robson, M. E.; Morrow, M.; Lee, M.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save